Table 3.
Comparison of baseline characteristics between patients with complete and noncomplete follow-up at 12 months.
| Characteristic | Patients who completed 12 months (n=120) | Patients who did not complete 12 months (n=70) | P value | |
| Age, n (%) | — | — | .38 | |
|
|
40-49 | 1 (1) | 0 (0) | — |
|
|
50-59 | 18 (15) | 17 (24) | — |
|
|
60-69 | 44 (37) | 24 (34) | — |
|
|
70 and older | 57 (48) | 29 (41) | — |
| Race, n (%) | — | — | .35 | |
|
|
White | 61 (51) | 38 (54) | — |
|
|
African American | 56 (47) | 29 (41) | — |
|
|
Other | 3 (3) | 1 (1) | — |
|
|
Unknown | 0 (0) | 2 (3) | — |
| Female, n (%) | 82 (68) | 42 (60) | .31 | |
| SABAa at baseline, puffs/day, mean (SD) | 3.1 (2.3) | 4.0 (1.6) | .18 | |
| Days with at least one sync at baseline, % | 94 | 88 | .09 | |
aSABA: short-acting beta-agonist.